• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名77岁男性的发疹性瘙痒性丘疹性汗孔角化症:罕见病例

Eruptive Pruritic Papular Porokeratosis in a 77-Year-Old Male: A Rare Case.

作者信息

Dookie Richard L, Subrt Paul, Tschen Jaime

机构信息

Clinical Documentation, Landmark Medical Center, Woonsocket, USA.

Dermatology, Katy Westside Dermatology, Houston, USA.

出版信息

Cureus. 2025 Aug 27;17(8):e91086. doi: 10.7759/cureus.91086. eCollection 2025 Aug.

DOI:10.7759/cureus.91086
PMID:40895689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393814/
Abstract

Eruptive pruritic papular porokeratosis (EPPP) is a rare inflammatory variant of disseminated superficial porokeratosis characterized by the sudden onset of pruritic papules, primarily affecting the extremities and trunk. We present the case of a 77-year-old male who developed EPPP without any underlying malignancy or immunosuppression. Histopathology confirmed EPPP, and the patient underwent treatment with topical lovastatin 2% ointment, followed by topical calcipotriene. This report highlights the clinical presentation, diagnostic workup, therapeutic interventions, and emerging insights into the management of this uncommon condition.

摘要

发疹性瘙痒性丘疹性汗孔角化症(EPPP)是播散性浅表性汗孔角化症的一种罕见炎症变体,其特征为瘙痒性丘疹突然发作,主要累及四肢和躯干。我们报告一例77岁男性患者,其患发疹性瘙痒性丘疹性汗孔角化症,无任何潜在恶性肿瘤或免疫抑制情况。组织病理学确诊为发疹性瘙痒性丘疹性汗孔角化症,该患者接受了2%局部用洛伐他汀软膏治疗,随后使用局部用卡泊三烯治疗。本报告重点介绍了这种罕见病症的临床表现、诊断检查、治疗干预措施以及管理方面的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/e9bbe043d9c7/cureus-0017-00000091086-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/484854e2bfd5/cureus-0017-00000091086-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/50ac20bac015/cureus-0017-00000091086-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/e4352bc4e0be/cureus-0017-00000091086-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/e9bbe043d9c7/cureus-0017-00000091086-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/484854e2bfd5/cureus-0017-00000091086-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/50ac20bac015/cureus-0017-00000091086-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/e4352bc4e0be/cureus-0017-00000091086-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629b/12393814/e9bbe043d9c7/cureus-0017-00000091086-i04.jpg

相似文献

1
Eruptive Pruritic Papular Porokeratosis in a 77-Year-Old Male: A Rare Case.一名77岁男性的发疹性瘙痒性丘疹性汗孔角化症:罕见病例
Cureus. 2025 Aug 27;17(8):e91086. doi: 10.7759/cureus.91086. eCollection 2025 Aug.
2
Eruptive pruritic papular porokeratosis or inflammatory form of disseminated superficial porokeratosis: a new case and review of the literature.发疹性瘙痒性丘疹性汗孔角化症或播散性浅表性汗孔角化症的炎症型:1例新病例并文献复习
Dermatol Online J. 2020 Apr 15;26(4):13030/qt8j7208hm.
3
Eruptive Pruritic Papular Porokeratosis (EPPP) Presenting as a Rare Facial Manifestation Associated With COVID-19: A Case Report.表现为与COVID-19相关的罕见面部表现的发疹性瘙痒性丘疹性汗孔角化症(EPPP):一例报告
Cureus. 2024 Apr 5;16(4):e57650. doi: 10.7759/cureus.57650. eCollection 2024 Apr.
4
Successful Treatment of Eruptive Pruritic Papular Porokeratosis in the Elderly with Tofacitinib: A Case Report.托法替布成功治疗老年患者的发疹性瘙痒性丘疹性汗孔角化症:一例报告
Clin Cosmet Investig Dermatol. 2023 Jul 6;16:1741-1747. doi: 10.2147/CCID.S412495. eCollection 2023.
5
Disseminated Superficial Actinic Porokeratosis播散性浅表性光化性汗孔角化症
6
First case of penile porokeratosis from Nepal: a case report.尼泊尔首例阴茎汗孔角化症:病例报告。
Ann Med Surg (Lond). 2025 May 20;87(7):4614-4617. doi: 10.1097/MS9.0000000000003403. eCollection 2025 Jul.
7
A Report of Eruptive Pruritic Papular Porokeratosis Treated with Abrocitinib.用阿布昔替尼治疗发疹性瘙痒性丘疹性汗孔角化症的报告。
Clin Cosmet Investig Dermatol. 2023 Aug 14;16:2223-2227. doi: 10.2147/CCID.S424310. eCollection 2023.
8
Eruptive pruritic papular porokeratosis: a pruritic variant of porokeratosis.发疹性瘙痒性丘疹性汗孔角化症:汗孔角化症的一种瘙痒性变体。
J Dermatol. 2006 Nov;33(11):813-6. doi: 10.1111/j.1346-8138.2006.00185.x.
9
Porokeratosis汗孔角化症
10
A case of inflammatory disseminated superficial porokeratosis in a colon cancer patient.一名结肠癌患者发生炎症性播散性浅表性汗孔角化症的病例。
Ann Dermatol. 2009 May;21(2):150-3. doi: 10.5021/ad.2009.21.2.150. Epub 2009 May 31.

本文引用的文献

1
Porokeratoses: an update on pathogenesis and treatment.汗孔角化症:发病机制与治疗的最新进展
Int J Dermatol. 2025 Jan;64(1):62-71. doi: 10.1111/ijd.17411. Epub 2024 Aug 11.
2
Complete relief by omalizumab in eruptive pruritic papular porokeratosis.奥马珠单抗使发疹性瘙痒性丘疹性汗孔角化症完全缓解。
JAAD Case Rep. 2024 Apr 28;49:20-21. doi: 10.1016/j.jdcr.2024.04.030. eCollection 2024 Jul.
3
Eruptive Pruritic Papular Porokeratosis (EPPP) Presenting as a Rare Facial Manifestation Associated With COVID-19: A Case Report.表现为与COVID-19相关的罕见面部表现的发疹性瘙痒性丘疹性汗孔角化症(EPPP):一例报告
Cureus. 2024 Apr 5;16(4):e57650. doi: 10.7759/cureus.57650. eCollection 2024 Apr.
4
Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.汗孔角化症——关于常见临床变异型的遗传学、代谢组学、成像方法及管理的综合综述
Metabolites. 2023 Nov 26;13(12):1176. doi: 10.3390/metabo13121176.
5
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.局部洛伐他汀联合胆固醇乳膏与单独使用局部洛伐他汀乳膏治疗播散性浅表性光线性汗孔角化病的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2023 May 1;159(5):488-495. doi: 10.1001/jamadermatol.2023.0205.
6
Disseminated Superficial Actinic Porokeratosis (DSAP): A Case Report Highlighting the Clinical, Dermatoscopic, and Pathology Features of the Condition.播散性浅表性光化性汗孔角化症(DSAP):一例报告,突出该病症的临床、皮肤镜及病理特征
Cureus. 2022 Jul 16;14(7):e26923. doi: 10.7759/cureus.26923. eCollection 2022 Jul.
7
Eruptive pruritic papular porokeratosis or inflammatory form of disseminated superficial porokeratosis: a new case and review of the literature.发疹性瘙痒性丘疹性汗孔角化症或播散性浅表性汗孔角化症的炎症型:1例新病例并文献复习
Dermatol Online J. 2020 Apr 15;26(4):13030/qt8j7208hm.
8
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.局部应用胆固醇/洛伐他汀治疗掌跖角化病:一种针对发病机制的治疗方法。
J Am Acad Dermatol. 2020 Jan;82(1):123-131. doi: 10.1016/j.jaad.2019.08.043. Epub 2019 Aug 23.
9
Metabolic Induction of Trained Immunity through the Mevalonate Pathway.通过甲羟戊酸途径诱导训练有素的免疫代谢。
Cell. 2018 Jan 11;172(1-2):135-146.e9. doi: 10.1016/j.cell.2017.11.025.
10
Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review.播散性浅表性光化性汗孔角化症的光疗和激光治疗方式:一项系统评价
Lasers Med Sci. 2017 May;32(4):945-952. doi: 10.1007/s10103-017-2179-9. Epub 2017 Feb 27.